Vivo Bio Tech Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 128.49 million compared to INR 135.36 million a year ago. Revenue was INR 128.79 million compared to INR 135.45 million a year ago. Net income was INR 13.21 million compared to INR 1.49 million a year ago. Basic earnings per share from continuing operations was INR 0.89 compared to INR 0.1 a year ago. Diluted earnings per share from continuing operations was INR 0.89 compared to INR 0.1 a year ago.
For the nine months, sales was INR 336.93 million compared to INR 374.72 million a year ago. Revenue was INR 337.23 million compared to INR 374.87 million a year ago. Net income was INR 17.9 million compared to INR 5.86 million a year ago. Basic earnings per share from continuing operations was INR 1.2 compared to INR 0.4 a year ago. Diluted earnings per share from continuing operations was INR 1.201 compared to INR 0.4 a year ago.